Semaglutide is known to reduce the risk of serious heart disease. However, a new study published in the European Heart Journal suggests that this effect cannot be entirely explained by patients losing weight on the drug.
❓ Unknown
Semaglutide's Heart Disease Risk Reduction: Beyond Weight Loss
Just now
September 24, 2026
1 min read
📰 Medical Xpress
📋 Key Takeaway
A study published in the European Heart Journal indicates that semaglutide reduces the risk of serious heart disease beyond just weight loss. This finding is significant for understanding the drug's broader health implications. For Iran, this could influence healthcare policies and access to new treatments.
🏷️ Entities Mentioned
🌐
Translated from the original and edited for English readers. View original source →
Translation confidence: 100%
📰 Related Coverage
17 min ago •
After the Fall of Assad; How Israel Has Expanded Its Presence in Southern Syria?
18 min ago •
Iranian President Pezeshkian Critiques U.S. and Israel in UNGA Address
23 min ago •
Democratic Senator Urges Trump to Pressure Xi to Cease Support for Iran
25 min ago •
IAEA Director Addresses Remaining Nuclear Material in Iran
26 min ago •